Keywords: topotarget, 2nd-qtr, loss, widens, 1m, copenhagen, denmark-based
TopoTarget's 2nd-qtr loss widens to $17.1M
Article | 03 September 2007
Copenhagen, Denmark-based TopoTarget AS says that, for the six months ended June 30, 2007, operating loss amounted to 93.7 million Danish kroner ($17.1 million) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
